Abstract
There is pressure to introduce innovations earlier, for example, through Early Access to Medicine Schemes. This increases uncertainty because there are often lower levels of evidence than with more mature technologies. Decision makers apply scientific and societal values when considering new health technologies, but innovations with a high level of uncertainty may challenge these. Aimed at HTA specialists and those interested in decisions on innovative treatments, the panel will allow debate about ethics.
Lingua originale | English |
---|---|
Titolo della pubblicazione ospite | HTAi 2015 – 12th Annual Meeting |
Pagine | 1 |
Numero di pagine | 1 |
Stato di pubblicazione | Pubblicato - 2015 |
Evento | Global Efforts in Knowledge Transfer: HTA to Health Policy. HTAi 2015 – 12th Annual Meeting - Oslo Durata: 15 giu 2015 → 17 giu 2015 |
Convegno
Convegno | Global Efforts in Knowledge Transfer: HTA to Health Policy. HTAi 2015 – 12th Annual Meeting |
---|---|
Città | Oslo |
Periodo | 15/6/15 → 17/6/15 |
Keywords
- HTA